Clinical Relevance of Liquid Chromatography Tandem Mass Spectrometry as an Analytical Method in Microdose Clinical Studies
暂无分享,去创建一个
Toshihiko Ikeda | Kazuya Maeda | Yuichi Sugiyama | Makiko Kusama | Zenzaburo Tozuka | K. Maeda | Y. Sugiyama | M. Kusama | Naoe Yamane | N. Yamane | Z. Tozuka | T. Ikeda
[1] S. Ono. Ministry of Health, Labour and Welfare (MHLW, Japan) , 2007 .
[2] J. Posner,et al. The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple doses , 2004, European Journal of Clinical Pharmacology.
[3] R. C. Garner,et al. A Review of Human Phase 0 (Microdosing) Clinical Trials Following the US Food and Drug Administration Exploratory Investigational New Drug Studies Guidance , 2006, International Journal of Pharmaceutical Medicine.
[4] D. Musson,et al. Application of a novel ultra-low elution volume 96-well solid-phase extraction method to the LC/MS/MS determination of simvastatin and simvastatin acid in human plasma. , 2005, Journal of pharmaceutical and biomedical analysis.
[5] James L. Gilbert,et al. Rebuilding Big Pharma ’ s Business Model , 2022 .
[6] M. Kanai,et al. A concise synthesis of Tamiflu: third generation route via the Diels–Alder reaction and the Curtius rearrangement , 2007 .
[7] Yu-mei Chi,et al. Determination of donepezil hydrochloride (E2020) in plasma by liquid chromatography-mass spectrometry and its application to pharmacokinetic studies in healthy, young, Chinese subjects. , 2004, Journal of chromatographic science.
[8] R. Colin Garner,et al. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs , 2003, Nature Reviews Drug Discovery.
[9] R. Hargreaves,et al. Clinical biomarkers in drug discovery and development , 2003, Nature Reviews Drug Discovery.
[10] Yuichi Sugiyama,et al. Microdose clinical trial: quantitative determination of nicardipine and prediction of metabolites in human plasma. , 2009, Drug metabolism and pharmacokinetics.
[11] L. Babiss,et al. Toxicogenomics in predictive toxicology in drug development. , 2004, Chemistry & biology.
[12] Malcolm Rowland,et al. Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs , 2006, Clinical pharmacology and therapeutics.
[13] W G Laver,et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.
[14] M. Nakashima,et al. Phase I Study of MK-954, a New Angiotensin II Receptor Antagonist , 1995 .
[15] Jean W. Lee,et al. A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.
[16] Yuichi Sugiyama,et al. Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.